ZAGRAPA 0.25 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Ketotifen fumarate, KETOTIFÈNE BASE
Commercialized according to BDPM
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZAGRAPA 0,25 mg/ml, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- flacon(s) multidose(s) en polyéthylène de 5 ml
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Jul 2013
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63456907CIP74925048CIP133400949250486Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROGÉNOFUMARATE DE KÉTOTIFÈNEcollyre | 0,345 mg · 1 ml de solution | SA |
| KETOTIFÈNE BASEcollyre | 0,25 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.